Onconetix, Inc. (ONCO): Nasdaq/NYSE listing notice — Blue Water Biotech receives Nasdaq deficiency notice for late Q2 2023 10-Q filing

Onconetix, Inc.

Received Nasdaq deficiency notice on August 22, 2023 for failing to timely file Form 10-Q for quarter ended June 30, 2023.
Has 60 calendar days to submit a compliance plan; Nasdaq may grant extension until February 20, 2024.
Company cites ongoing review of employee expenditures as reason for delay; no timeline for filing given.
Notice does not immediately affect listing or trading of BWV common stock on Nasdaq.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

August 22, 2023, Blue Water Biotech, Inc. (the “ Company ”) received a deficiency notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company was not in compliance with Nasdaq’s continued listing standards (the “ Listing Rules ”) as set forth in Listing Rule 5250(c)(1) given the Company’s failure to timely file its quarterly report on Form 10-Q for the quarter ended June 30, 2023 (the “ 10-Q ”). Consistent with the Listing Rules, the Company has 60 calendar days from the date of the Notice to provide Nasdaq with a specific plan to achieve and sustain compliance with

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Onconetix, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-071247

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.